Innovating Works
Mostrando 1 al 20 de 66 resultados
healthRiskADAPT: User driven Health risk Assessment Services and Innovative ADAPTation options against Threats from H... SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT participó en un HORIZON EUROPE: HORIZON-MISS-2023-CLIMA-01 Transformative adaptation is gaining recognition as the appropriate response to climate change as the current adaptive measures reach their...
2024-05-16 - 2028-10-31 | Financiado
IMCI-PLUS: POINT OF CARE ULTRASOUND FOR PEDIATRIC LOWER RESPIRATORY TRACT INFECTIONS IN SUB-SAHARAN AFRICA IMCI-PLUS is an inter-disciplinary, Pan-African-EU research partnership, with emphasis on capacity strengthening and mutual learning, to imp...
2024-03-05 - 2028-09-30 | Financiado
PLAN-B: The Path Towards Addressing Adverse Impacts of Light and Noise Pollution on Terrestrial Biodiversity... SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT participó en un HORIZON EUROPE: HORIZON-CL6-2023-BIODIV-01 The rate of global biodiversity decline is unprecedented and accelerating. Urban sprawl, population growth and industrialization bring previ...
2023-10-04 - 2027-12-31 | Financiado
eWHORM: Enabling the WHO-Roadmap 2030 SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 We will establish for the first time in NTDs an adaptive clinical trial platform and improve clinical research infrastructure in four SSA co...
2023-03-02 - 2028-03-31 | Financiado
INOVEC: a research and InNOvation Partnership for enhancing the surveillance and control of mosquito VECtors... SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT participó en un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01 Over the past 10 years, arboviral diseases, such as dengue, Zika, chikungunya and yellow fever, have (re)emerged with increasing prevalence...
2022-11-04 - 2026-12-31 | Financiado
GOLIAT: 5G expOsure, causaL effects, and rIsk perception through citizen engAgemenT SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT participó en un HORIZON EUROPE: HORIZON-HLTH-2021-ENVHLTH-02 Despite the rapid growth in novel applications of wireless technology, comparatively little is known about their potential impacts on health...
2022-05-23 - 2027-05-31 | Financiado
ETAIN: Exposure To electromAgnetic fIelds and plaNetary health SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT participó en un HORIZON EUROPE: HORIZON-HLTH-2021-ENVHLTH-02 The ongoing introduction of new telecommunication technologies (5G now, 6G next) comes with changes in exposure patterns and of biological i...
2022-05-20 - 2027-05-31 | Financiado
DRUGSBUGS: Improved therapies for soil transmitted helminthiases exploring pharmacomicrobiomics novel drugs a... SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT tramitó un H2020: ERC-2020-ADG An estimated 1.5 billion people are infected with soil-transmitted helminths (STHs) causing a global burden of 1.9 million disability-adjust...
2021-07-14 - 2026-12-31 | Financiado
PREPARE4VBD: A Cross Disciplinary Alliance to Identify PREdict and prePARe for Emerging Vector Borne Diseases SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT participó en un H2020: H2020-SFS-2018-2020 PREPARE4VBD builds on the conviction that a true shift in our ability for early detection, prediction and control of vector-borne diseases (...
2021-05-05 - 2025-08-31 | Financiado
EPOCH: Women s political EmPOwerment and Child Health SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT tramitó un H2020: H2020-MSCA-IF-2020 Although increasing women’s representation in political decision-making has the potential to significantly improve child health and developm...
2021-03-09 - 2024-01-31 | Financiado
ALIVEAfrica: Animals Livelihoods and Well being in Africa SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT participó en un H2020: ERC-2020-STG Animals are central to the livelihood strategies of millions of people in sub-Saharan Africa. Across the continent, animals provide sources...
2021-03-05 - 2026-09-30 | Financiado
NeoIPC: Establishing innovative approaches for optimal infection prevention of resistant bacteria in NICUs b... SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT participó en un H2020: H2020-SC1-BHC-2018-2020 Around 10% of newborns in Europe will be admitted to a neonatal intensive care unit (NICU). Critically ill babies are a highly vulnerable po...
2021-02-18 - 2026-03-31 | Financiado
ECOEVODRTB: Linking within host and between host evolution of multidrug resistant Mycobacterium tuberculosis SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT tramitó un H2020: ERC-2019-ADG Mycobacterium tuberculosis (Mtb), the etiologic agent of tuberculosis (TB), is the main cause of human deaths due to infection in general, a...
2020-07-24 - 2026-01-31 | Financiado
MepAnti: Exploiting the methylerythritol phosphate pathway as a source of drug targets for novel anti infecti... SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT participó en un H2020: H2020-MSCA-ITN-2019 Anti-infective resistance is a serious global healthcare issue, calling for the development of compounds with a novel mode of action. An int...
2020-05-12 - 2024-09-30 | Financiado
CORESMA: COVID 19 Outbreak Response combining E health Serolomics Modelling Artificial Intelligence and Im... SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020 Among the biggest challenges in the COVID-19 outbreak are the lack of triangulation of clinical, epidemiologic and immunological information...
2020-04-15 - 2023-12-31 | Financiado
EPOCHAL: Beyond seasonal suffering Effects of Pollen on Cardiorespiratory Health and Allergies SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT tramitó un H2020: ERC-2019-STG As climate change increases the duration and intensity of the pollen season, allergies to airborne pollen are increasingly common in Europe....
2019-12-19 - 2025-07-31 | Financiado
DRTB-HDT: STRATIFIED HOST DIRECTED THERAPY FOR DRUG RESISTANT TUBERCULOSIS A RANDOMIZED CONTROLLED MULTI CENT... SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT tramitó un H2020: H2020-SC1-BHC-2018-2020 Tuberculosis is a leading cause of morbidity and mortality worldwide. Current TB treatments are inadequate, requiring patients closely adher...
2019-12-19 - 2025-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.